BUZZ-Medtronic climbs after Q4 results beat estimates

Medtronic

Medtronic

MDT

0.00

Updates

** Shares of medical device maker Medtronic MDT.N rise 5.3% to $77.69

** MDT reports Q4 adj. profit of $1.55/shr vs analysts' average estimate of $1.54/shr - LSEG data

** Co's quarterly revenue of $9.81 billion beats analysts' average expectation of $9.63 billion on strong demand for its heart devices

** MDT forecasts fiscal 2027 adj. profit in the range of $5.90 to $6 per share vs analysts' expectation of $6.06 per share

** Up to last close, stock was down 23% YTD



This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.